Center-Authored Papers
Filters: Author is O'Donnell, Paul V [Clear All Filters]
Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):265-272. Abstract
.
2012.
.
2012.
.
2011.
Alternative transplant donor sources: is there any consensus? Current opinion in oncology. 25(2):173-9. Abstract
.
2013.
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(10):1830-8. Abstract
.
2015.
Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 24(7):1276-82. Abstract
.
2010.
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(11):1279-87. Abstract
.
2008.
The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(3):344-51. Abstract
.
2009.
Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer.. Journal of comparative effectiveness research. 3(2):135-44. Abstract
.
2014.
Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
.
2010.
EBMT transplant centers with FACT-JACIE accreditation have significantly better compliance with related donor care standards.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
.
2015.
.
2015.
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(10):1537-45. Abstract
.
2011.
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(6):641-50. Abstract
.
2008.
Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor.... Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(10):1867-1873. Abstract
.
2016.
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
.
2009.
.
2017.
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2017728428. Abstract
.
2017.
Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(31):3497-505. Abstract
.
2014.
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):482-9. Abstract
.
2010.
A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients.. Cancer chemotherapy and pharmacology. 63(3):391-401. Abstract
.
2009.
.
2016.
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.. Cancer chemotherapy and pharmacology. 72(3):607-18. Abstract
.
2013.
A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients.. Cancer chemotherapy and pharmacology. 69(1):263-272. Abstract
.
2012. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)